发明授权
US08633205B2 Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein kinases
失效
取代的吡咯并[2,3-d]嘧啶作为蛋白激酶的抑制剂
![Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein kinases](/docs/US/2014-01-21/US08633205B2/abs.jpg.600x600.jpg)
- 专利标题： Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein kinases
- 专利标题（中）： 取代的吡咯并[2,3-d]嘧啶作为蛋白激酶的抑制剂
-
申请号： US11346048申请日： 2006-02-02
-
公开(公告)号： US08633205B2公开(公告)日： 2014-01-21
- 发明人: Mark Ledeboer , Albert Pierce , Guy Bemis , Luc Farmer , Tiansheng Wang , David Messersmith , John Duffy , Francesco Salituro , Jian Wang
- 申请人： Mark Ledeboer , Albert Pierce , Guy Bemis , Luc Farmer , Tiansheng Wang , David Messersmith , John Duffy , Francesco Salituro , Jian Wang
- 申请人地址： US MA Cambridge
- 专利权人： Vertex Pharmaceuticals Incorporated
- 当前专利权人： Vertex Pharmaceuticals Incorporated
- 当前专利权人地址： US MA Cambridge
- 代理商 Lisa A. Dixon; Susan C. Kelly
- 主分类号： C07D487/04
- IPC分类号： C07D487/04 ; A61K31/519 ; A61K31/497 ; A61P35/00 ; A61P37/06 ; A61P25/28
![Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein kinases](/abs-image/US/2014/01/21/US08633205B2/abs.jpg.150x150.jpg)
摘要：
The present invention relates to compounds of the following formula: which are useful as inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.